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The incidence of deep venous thrombosis (DVT) is highly dependent on the
population studied and on the definition of DVT used. Moreover, in Korea, the
prevalence of DVT is increasing (Table 1). The true incidence of this disease as
quoted by previous epidemiological studies are generally underestimated because
study populations have been restricted to those who present at hospitals and are
then diagnosed as having DVT. Furthermore, one autopsy study concluded that
up to 50% of venous thromboembolisms is overlooked ante mortem.
1
Two main complications of DVT are pulmonary embolism and post-thrombotic
syndrome (PTS), and the incidence of PTS is higher in patients that only receive
anticoagulation for the management of DVT.
2 Most physicians consider that the
delivery of a thrombolytic agent into a thrombus is more effective than systemic
anticoagulation because this procedure reduces the complication rate of systemic
anticoagulation.
1,2 Contemporary venous thrombectomy has been reported to
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Purpose: The purpose of this study is to evaluate treatment outcomes in patients with symptomatic deep vein
thrombosis (DVT) who had undergone a catheter-directed thrombolysis with conventional aspiration thrombectomy
for the treatment of lower extremity deep vein thrombosis. Materials and Methods: The authors retrospectively
reviewed the records of 74 patients (mean age 61 ± 15) that underwent a catheter-directed thrombolysis with
conventional aspiration thrombectomy. A retrieval inferior vena cava (IVC) filter was placed to protect against a
pulmonary embolism in 60 patients (81%). Stenting and balloon angioplasty were performed in 37 patients (50%)
under the left common iliac vein compression. Results: Sixty-seven patients (91%) showed a clinical improvement
within 48 hours, but seven patients (9%) showed no improvement. Multi detector computerized tomographic
venography (MDCT venography) at discharge showed no thrombus in 15 patients (20%) and partial thrombus in 52
(70%). Twenty-eight patients (38%) developed post-thrombotic syndrome at 3.0 ± 4.2 months postoperatively. Six
patients (8%) were admitted due to DVT recurrence at a mean of 5.6 ± 7.4 months postoperatively. Sixty-nine
patients underwent follow up MDCT venography at 5.7 ± 5.6 months. fifty (72%) of these showed no thrombus, 15
(22%) partial thrombus, and 4 (6%) showed obstruction. Twentyeight of 61 (46%) were asymptomatic, twentyeight
(46%) had moderate improvement, and four (6%) were mildly improved by a telephone interview (81%) at 22.8 ±
10.7 months postoperatively. Conclusion: Catheter-directed thrombolysis with conventional aspiration thrombec-
tomy is an effective treatment for lower extremity deep vein thrombosis and produces satisfactory clinical results.
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INTRODUCTIONimprove early and long term results in extensive iliofemoral
DVT as compared with simple catheter-directed throm-
bolysis.
3,4 Furthermore, several percutaneous thrombectomy
devices have been recently released,
4,5 and replaced conven-
tional thrombectomy. The aim of this study is to evaluate
the clinical efficacy of catheter-directed thrombolysis with
conventional aspiration thrombectomy for the treatment of
lower extremity deep vein thrombosis, and to document
clinical outcomes.
The hospital records of 74 patients diagnosed with sympto-
matic DVT from October 2004 to December 2007 were
analyzed retrospectively. The male/female ratio was 34/40,
and mean patient age was 60 ± 15 years. Sixty-eight patients
(92%) complained of leg swelling, and 40 patients (54%)
of leg pain. Mean symptom duration of the patients was
8.4 ± 12.1 days, with a median of 4 days and a range of 1
to 60 days. Patient characteristics are summarized in Table
2. Risk factors for hypercoagulability are listed in Table 3.
Diagnoses were established by color duplex ultrasound
imaging or MDCT venography or venography, which was
performed in an angiography suite. We performed MDCT
pulmonary angiography to detect for a pulmonary embolism
in all patients.
All patients underwent aspiration thrombectomy first
and then a catheter-directed thrombolysis. A prophylactic
retrievable IVC filter (OptEase, Cordis, Miami, FL, USA)
was inserted in 15 patients with a free floating thrombus
into the IVC or common iliac vein, in 10 patients diag-
nosed with pulmonary embolism at admission, or in 35
patients with both. For venous access, a patient was placed
in a prone position and the ipsilateral popliteal vein was
accessed using a micropuncture needle kit (Micropuncture
introducer set, Cook, Bloomington, IN, USA) under
ultrasound guidance (Logiq P5 premium, GE, Seongnam,
Korea). After an initial ascending venogram had been
obtained using a 9 F introducer sheath (Radifocus intro-
ducer II, Terumo, Leuven, Belgium), direct aspirations of
the embolus were performed several times using an 8F
guiding catheter (Vistabrite tip, Cordis, Miami, FL, USA)
while maintaining negative pressure with a 50 mL syringe.
Stent placement was indicated if the left common iliac vein
was compressed after embolus aspiration. Stents were
placed over a guide wire into the left common iliac vein
and were typically between 10 to 14 mm in diameter and
60 to 90 mm long (Wallstent, Boston Scientific, Galway,
Ireland). Stent dilatation was achieved using a balloon
catheter (BlueMax 20, Boston Scientific, Galway, Ireland). 
After the thrombectomy with or without stent placement,
thrombolysis was performed by placing a 20 cm multi-side
hole thrombolysis catheter (Multisideport catheter infusion
set, Cook, Bloomington, IN, USA) into the thrombosed
vein. The procedure started by infusing urokinase (GCC-
Urokinase, Green Cross, Yongin, Korea) at a rate of 80,000
to 120,000 IU/hour; the rate used depended on the patient’s
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MATERIALS AND METHODS 
Table 1.Incidences of New or Recurring DVT in Korea
Year 2003 2004 2005 2006 2007
No. of patients* 35 37 40 42 51
DVT, deep vein thrombosis.
Data was provided by the Korean Health Insurance Review & Assessment Service.
*per 100,000 of the population. 
Table 2.Patient Characteristics (n = 74)
Age (mean ± SD, yr) 61 ± 15
Gender (male) 34 (46%)
Symptoms
Leg swelling 68 (92%)
Leg pain 40 (54%)
Duration (mean ± SD) 8.4 ± 12.1 (days)
Pulmonary embolism at admission 45 (61%)
Predisposing factors
May-Thurner syndrome 34 (46%)
Immobilization 23 (37%)
Hypercoagulability 18 (29%)
Previous operation 12 (19%)
Obesity 7 (11%)
Previous DVT 7 (11%)
Malignancy 2 (3%)
Location of thrombus
Left limb 59 (80%)
Suprainguinal 57 (77%)
SD, standard deviation; DVT, deep vein thrombosis.
Table 3.Primary Hypercoagulable States (n = 18, 24%)
Protein C deficiency 5 (28%)
Protein S deficiency 4 (22%)
Homocystein abnormality 4 (22%)
Factor V deficiency 2 (11%)
Betchet’s disease 2 (11%)
Polyarteritis nodosa 1 (6%)condition, amount of thrombus, and the patient’s weight.
Venography was carried out 12 hour later to evaluate the
progress of thrombolysis and to correct the catheter position.
Infusion was continued for a further 24 hours if the thro-
mbus had not completely resolved. Anticoagulation was
carried out after thrombolysis by continuously infusing
heparin to a partial thromboplastin time of 70-90 seconds,
which was subsequently checked at 6-hour intervals. The
subsequent treatment protocol included oral anticoa-
gulation with warfarin to a target international normalized
ratio of 2.0-2.5 for 3 months. The retrieval IVC filter was
removed at 2 weeks postoperatively from 46 (76%)
patients with optimal patency by MDCT venography. It
was left behind for permanent use in 14 (24%) patients
with suboptimal patency by MDCT venography.
Thrombus removal was defined as complete if the MDCT
venogram at discharge showed no evidence of a residual
clot (Fig. 1A), and partial thrombus removal was defined if
any residual clot was visualized (Fig. 1B). Treatment
failure was defined as near total obstruction of the venous
lumen by thrombus (Fig. 1C). Follow-up examinations
were performed at 6 months postoperatively by MDCT
venography. In addition, a telephone interview was con-
ducted with each patient during September 2008 by a
trained nurse to determine the clinical outcome and clinical
symptoms; outcomes were defined as asymptomatic,
moderately improved, mildly improved, unchanged,
mildly worsened, moderately worsened, and considerably
worsened.
Thrombosis was located on the left side in 58 (78%) patients
and on the right side in 16 (22%) patients. The IVC was
affected in 6 (8%) patients. Thrombosis was involved up to
the supra inguinal segments in 57 (77%) patients, and up to
the infra inguinal segments in 17 (23%) patients. Pulmonary
embolism was diagnosed in 45 (61%) patients. Clinical
improvement, as defined by a decrease in pain and/or swell-
ing of the affected extremity within 48 hours of intervention,
was displayed by 67 (91%) patients. Primary stent place-
ment for segmental stenosis was necessary in 37 (50%)
patients. The mean urokinase infusion time was 31 (8-48)
hours, and the mean amount of urokinase delivered was
2,630,000 ± 1,083,000 units. Complete thrombus removal
was achieved in 15 (20%) patients, and partial thrombus
removal in 52 (70%) by MDCT venography at discharge.
Treatment failure occurred in 7 (9%) patients (Table 4).
Four (5%) bleeding complications related to thrombolysis
occurred. However, only one patient had a major bleeding
complication and retroperitoneal hematoma, and required a
blood transfusion. DVT recurrence was diagnosed with a
Doppler study and MDCT venography in 6 (8%) patients.
Catheter Thrombolysis and Thrombectomy
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RESULTS
Fig. 1.MDCT angiograms showing complete thrombus removal (A), partial thrombus removal (B), and treatment failure (C). Each A-1, B-1, C-1 are in an axial view before
thrombolysis at the level above the iliac vein (arrow), and A-2, B-2, C-2 are in an axial view after thrombolysis at the level of the superficial femoral vein (arrow). MDCT,
multi detector computerized tomographic.
Pre-thrombolysis Post-thrombolysis Pre-thrombolysis Post-thrombolysis
A-1 A-2
B-1 B-2
C-1 C-2Yong Sun Jeon, et al.
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These patients were readmitted for further treatment. Post-
thrombotic syndrome, defined as affected limb edema,
pigmentation, pain, and/or venous insufficiency by a
Doppler study, was noted in 28 (38%) patients at 3.0 ± 4.2
months postoperatively. MDCT venography showed
complete thrombus removal in 50 (72%) patients, partial
removal in 15 (22%), and treatment failure in 4 (6%)
during the 5.7 ± 5.6 month follow-up (Table 4). The mean
clinical follow-up interval was 22.8 ± 10.7 months, and 61
patients among the 74 patients were accessed via a tele-
phone interview (81%). Twenty-eight of the 61 (46%) tele-
phone patients were asymptomatic, twenty-eight (46%)
had moderate improvement, and four (6%) were mildly
improved.
Epidemiologic studies have shown that DVT is highly pre-
valent in western populations. The incidence of venogra-
phically confirmed DVT in Sweden has been reported to
be as high as 160 cases of new or recurring DVT per
100,000 of the population per year,
6 and 116,000 to more
than 250,000 new cases of clinically recognized DVT per
year are recorded in the United States.
7 The Korean Health
Insurance Review & Assessment Service reported that in
2007, 51 per 100,000 of the population were treated for new
or recurring DVT, and that the incidence of this disease is
increasing (Table 1). The causes of this increase are multi-
factorial, but the main reason is likely to be a Westernization
of diet resulting from economical development in the past
20 years. The number of May-Thurner syndrome patients
was 34 (46%), which was higher than that reported pre-
viously.
5 There is a reason why the left limb was more
frequently involved (80% vs. 20%) in our population.
Patients with anatomical compression of the left common
iliac vein by the left common iliac artery are prone to
develop venous flow stasis in the left leg. Husmann, et al.
8
reported that combined thrombolysis and stenting of a
common iliac vein obstruction is effective. Our results
showed a good 6 months MDCT venography follow-up in
patients with stent placement. The incidence of hypercoa-
gulable disorder was 29%, which is lower than the 78%
previously reported.
9 Differences between the above-men-
tioned predisposing risk factors may be due to racial
differences.
Numerous studies have reported positive outcomes for
catheter-directed thrombolysis in acute DVT.
1-3,5 Mewissen,
et al.
10 documented a complete resolution rate of 31%, a
partial rate of 52%, and a failure rate of 17%, whereas
Verhaeghe, et al.
11 reported a complete resolution rate of
79% and a failure rate of 21%. In the present study, the
complete resolution rate was 20%, the partial resolution
rate was 70%, and the failure rate was 10%. Our immediate
complete resolution rate was lower than those of these
other reports. The duration of symptoms at the onset of
lytic therapy was predictive of lytic outcome.
10 For acute
cases (less than 10 days), the prevalence of complete lysis
was 34% compared with 19% in cases with a history of
chronic DVT (> 10 days).
10 The median was 4 days duration
of symptoms in our cases although the range was up to 60
days. It may result from different patients’ compositions
such as more May-Thurner syndrome patients, or higher
rate of suprainguinal DVT involvement than other reports. 
Catheter directed thrombolysis with adjunctive mechani-
cal thrombus removal is becoming the standard for the
catheter based management of DVT,
1,2 and contemporary
venous thrombectomy has substantially improved early
and long term results.
1-3,5 Numerous devices have been
recently released for pharmacomechanical thrombolysis.
3,5
We performed a mechanical thrombectomy by manual
aspiration, i.e., we did not use the thrombectomy devices.
It is difficult to use newly developed catheters, such as the
Trellis catheter, the AngioJet system, or an ultrasound
incorporating system in our public health system because
public health insurance does not cover the cost of the
catheters. However, Lin, et al.
5 showed no statistical differ-
ence between thrombus removal rates for the pharmaco-
mechanical thrombectomy using the AngioJet system and
catheter direct thrombolysis. The complete thrombus free
rate was 67% in the present study and 75% for Angiojet
catheter-directed thrombolysis in the report by Lin, et al.
5
The conventional manual aspiration can be an alternative
for thrombectomy in the absence of special catheter systems.
Acute pulmonary embolismis a major morbidity of acute
DVT.
1,2 In our study cohort, we used a temporary IVC filter
Table 4.Clinical Results
Clinical improvement within 48 hours 67 (91%)
Treatment success at discharge
Complete thrombus removal 15 (20%)
Partial thrombus 52 (70%)
Treatment failure 7 (10%)
On 6 months follow-up
Complete thrombus removal 50 (72%)
Partial thrombus 15 (22%)
Treatment failure 4 (6%)
DVT recurrence 6 (8%)
Post-thrombotic syndrome 28 (38%)
Complications
Hematoma formation requiring transfusion 1 (1%)
Minor bleeding 3 (4%)
DVT, deep vein thrombosis.
DISCUSSIONCatheter Thrombolysis and Thrombectomy
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in 60 (81%) of the patients to prevent thrombus emboliza-
tion during the procedures. Currently, prophylactic IVC
filter placement is performed without departmental gui-
delines. IVC filter insertion is recommended in patients
with a free floating IVC thrombus that is longer than 5
cm.
1 The incidence of preoperative pulmonary embolism
at admission in our study was 61%, which was higher than
the 10-26 % previously reported.
11,12 This may have been
due to a higher rate of suprainguinal DVT involvement in
our patients (77%), or routine preoperative MDCT pulmo-
nary angiography check up. Post-thrombotic syndrome,
which is the most important late complication, has been
reported to occur in 29% to 79% of acute DVT cases.
14
Valvular insufficiency and residual obstruction are primary
contributors to venous hypertension, which may result in
limb edema, hyperpigmentation, or ulceration.
15 Experi-
mental reports on acute DVT in canine models have
demonstrated that thrombolysis preserves endothelial
function and valve competence.
16 Early post-thrombotic
syndrome in our cohort at a 3 month follow-up (39%) could
be lower on later follow up periods, considering that the
20% complete thrombus removal rate at discharge imp-
roved to 67% on a 6 months follow-up. Our mid-term
follow up via telephone interview (81%) showed asympto-
matic in 46% of patients and moderate improvement in
46%.
The reported complications of catheter-directed throm-
bolysis are bleeding, pulmonary embolism, and death.
1,2 In
the present study, there was no death. 5% of patients de-
veloped a bleeding complication, but only one case had a
retroperitoneal hematoma and required a transfusion. 
We conclude that catheter-directed thrombolysis by
conventional aspiration thrombectomy is an effective treat-
ment for lower extremity deep vein thrombosis, and the
clinical results achieved were satisfactory.
This work was supported by research grant from INHA
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